Inside Innovation

Following a blockbuster deal with pharmaceutical company Merck, Seattle Genetics released plans to build a $300 million manufacturing facility, two to three times the size

Washington was named the best state to work in during the COVID-19 pandemic, according to a report released by Oxfam America. The study looked at

Investment into the Seattle biotech scene continues as Lumen Bioscience announced it received $16 million in Series B funding. The startup, led by former Adaptive

Athira Pharma, which develops therapies for brain diseases such as Alzheimer’s and Parkinson’s, filed for an IPO last week. Athira’s regenerative technology works to rebuild

Nanodropper, a medical device startup launched by a group of University of Washington students, announced that it received $500,000 in funding from the United States

Amid an economic downturn, Washington state’s life science industry is growing and hiring for hundreds of open positions at all levels. To fuel this expansion,